Investment of $8.5 million to the Montreal General Hospital

(Photo: Martine Alfonso, Honourable Navdeep Bains, Dr. Bruce Mazer, Jean-Guy Gourdeau)

March 2, 2017 – The Montreal General Hospital Foundation salutes today’s announcement by the Government of Canada. Through the Minister of Innovation, Science and Economic Development, Navdeep Bains, an important investment of $8.5 million will be made to the Montreal General Hospital (MGH) for research facilities, renovations and important medical advancement programs. With the generosity of its donors, the Montreal General Hospital Foundation is also proud to partner on this important high-level initiative by contributing $1.7 million.

“In total, 1.1 billion dollars are being invested in our academic institutions here in Québec – a significant amount of money for research, education, science and innovation which are all high priorities for the Government of Canada,” announced Honourable Bains.

“The Montreal General Hospital is an integral part of the McGill University Health Centre (MUHC) and McGill University and this grant will help us to continue building on our historical leadership of medical achievements and excellence in teaching and research,” expressed Martine Alfonso, Interim President and Executive Director of the MUHC. “We are proud that today, still, the Montreal General Hospital offers specialized and ultraspecialized care in the areas of Trauma, Thoracic Surgery, Oncology, Orthopaedics and Mental health, just to name a few.”

There are many important projects at the MGH that will benefit from this funding, namely the new Centre for Outcomes Research and Evalutation (CORE), the Centre of Innovative Medicine (CIM) and the Surgical Innovation Program (SIP).

  • CORE focuses on patient and population-oriented research and training. Important CORE space will be provided which will accommodate developmental activities related to research, such as focus groups and participatory research.
  • CIM will be a dedicated clinical research facility which will hold important clinical trials with the goal of transforming discoveries into new treatments that will benefit patients and the community.
  • SIP is a program that combines the knowledge of multiple fields; medicine, engineering and business. This bright and talented group will focus on development of strategies and best practices to eventually commercialize the discoveries for even higher quality patient care.

“The Montreal General Hospital Foundation’s mandate is to provide support for our Hospital’s growing needs to ensure consistent delivery of high quality patient care for which we are highly reputable. Programs such as CORE, CIM and SIP will only strengthen our leadership in research, worldwide. We are immensely proud to be a part of these vital developments at the MGH,” said Jean-Guy Gourdeau, President of the Montreal General Hospital Foundation. “Thank you to the Governments of Québec and Canada for their outstanding commitment which will allow us to remain world leaders in patient care, teaching and research. We greatly value this strong partnership that has been built.”